Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30168086 | 1.00 | NPC1 (0.36) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL5950443 | 0.86 | NOS3 (0.33) | NOS3NOS1NOS2 | |
| SCHEMBL20207326 | 0.80 | APLNR (0.32) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL29613118 | 0.80 | UHRF1 (0.33) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL2339196 | 0.80 | UHRF1 (0.33) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL23612822 | 0.80 | APLNR (0.32) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL18523078 | 0.80 | APLNR (0.32) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL8053862 | 0.80 | UHRF1 (0.33) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL20204744 | 0.80 | APLNR (0.35) | NPC1RAB9ASMN1; SMN2LMNAMAPT | |
| Hydrochloric Acid SCHEMBL17823742 | 0.78 | UHRF1 (0.32) | NPC1RAB9ASMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 712 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119931891-A | Pediococcus acidilactici capable of producing various pyrazines and application thereof | 北京工商大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119842550-A | Pediococcus pentosaceus capable of producing various pyrazines and application thereof | 北京工商大学 | 2025-04-18 | — | — | CN | claimed |
| US-11365370-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-21 | — | — | US | claimed |
| EP-3809876-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243869-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2019-12-26 | — | — | WO | claimed |
| US-9949911-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2018-04-24 | — | — | US | claimed |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-02 | — | — | US | claimed |
| US-20170267944-A1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-21 | — | — | US | claimed |
| EP-3139902-A2 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2017-03-15 | — | — | EP | claimed |
| EP-2654432-B1 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | ROOMBIOTIC GMBH (AT) | 2017-02-08 | — | — | EP | claimed |
| EP-2931236-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931234-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter and Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| US-20140179722-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| WO-2014093819-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093747-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| EP-2654432-A2 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | Research Center Pharmaceutical Engineering GmbH (AT) | 2013-10-30 | — | — | EP | claimed |
| WO-2012085255-A2 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (AT) | 2012-06-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | NPC1 2758/4885RAB9A 3127/4885SMN1; SMN2 4196/4885 |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | LPO, GPX4, DEK | NPC1 2758/4885RAB9A 3127/4885SMN1; SMN2 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.